John Guanjing Zhang’s Post

https://buff.ly/4cXCfSY SelSym, a pioneering startup, is addressing the challenge of platelet storage limitations. Due to their short lifespan, platelets cannot be stored for future use, despite a substantial number of donations. The innovative solution being developed by SelSym involves the utilization of soft artificial platelets to effectively control bleeding. This groundbreaking approach holds promise in revolutionizing the way bleeding is managed. #MedicalInnovation #BleedingControl

Sergei Petukhov, DVM co-founder and CEO of Metallomix Inc. a Cure resident company that is developing disease-modifying drugs based on isotopically modified zinc for the treatment of diseases such as cancer, neurodegenerative diseases and metabolic disorders. Read more to find out Petukhov’s five essential tips for biotech entrepreneurs on building a resilient company. https://lnkd.in/dvc5RNW8

The #biotech entrepreneurial journey can be equal parts frustrating, exhilarating, and rewarding. In the early stages, it's essential to keep an eye on scalability and lean on partners who can help you reach your next milestone quickly and cost-effectively. Our customers attest that RoosterBio can be a powerful resource for #advancedtherapy startups by providing: ✅ Scalable and economical raw materials to take you from bench to clinic ✅ Technical guidance along the way to optimize your chance of success ✅ Expert-led services to advance your research quickly and efficiently with reduced overhead cost Learn more: https://lnkd.in/eMGMeNV3 #advancedtherapies #regenerativemedicine #gotomarket #biotechinnovation #startup

Healthcare diagnostics startup Neuranics raises $700K in seed round: Neuranics, a healthcare diagnostics startup, has raised $700K in its seed round led by Inflection Point Ventures (IPV).  The proceeds will be used for technology development and clinical validation, enabling the company to progress toward commercial production post-CDSCO licensing.  Founded in 2021 by Praveen Kumar and Ashutosh Patra, Neuranics is developing a point-of-care blood analyzer capable of delivering complete blood count (CBC) results in less than 10 minutes using just a finger-prick sample. The device, designed for primary and emergency settings, offers low maintenance and high efficiency, making it a game-changer for the healthcare industry. At the same time, life-saving treatments for critical conditions like sepsis, severe anemia, and thrombocytopenia, especially in dengue patients, can be initiated promptly, ensuring timely and effective care.  The company has a patent granted, received the CDSCO Test License, and Ethical Approval from AIIMS Delhi, and progressing through clinical trials.  So far, Inflection Point Ventures has invested over Rs 790 crore across over 210 startups. #Healthcare #Diagnostics #Startup

Empowering the Next Wave of Unicorns: Startup Karnataka's KAN and ELEVATE Initiatives The Karnataka Acceleration Network (KAN) aims to support 302 growth-stage startups over the next three years through mentorship, market access, and funding, especially in areas beyond Bengaluru. KAN offers a structured pathway for startups looking to scale, making Karnataka an ideal launchpad for growth. KAN builds on the ELEVATE 2024 initiative, a seed fund program started in 2016. With Rs 224.06 crore committed, ELEVATE has supported 983 early-stage startups, making Karnataka the first state with such comprehensive startup support. This commitment has established Karnataka as a leader in fostering entrepreneurship. With Bengaluru home to 45 of India’s 112 unicorns, valued at $161 billion, KAN and ELEVATE aim to propel Karnataka into the global top three startup ecosystems. By addressing funding gaps and promoting scalability, these programs are a game-changer for emerging founders and Karnataka’s position as an innovation hub. Kudos to Karnataka govt.(Priyank M Kharge, CM Siddaramaiah, Dr. Ekroop Caur) for leading the way in India’s startup revolution! If you or someone you know could benefit from this funding, explore application details here- https://lnkd.in/gYGkfNFC #KarnatakaStartups #IndianEntrepreneurship #StartupEcosystem #Innovation

🚀 Calling all trailblazing entrepreneurs! 🚀 DESCA is proud to support Startup302 and help empower diverse founders driving change and innovation. Applications are now open for Delaware’s 5th annual Startup302 competition, running January 2–26! If you're part of a technology-enabled startup with high-growth potential and have at least one founding team member from an underrepresented group, this is your chance to shine. 🏆 Prizes include: 💰 Over $100,000 in cash grants 🤝 Mentorship opportunities 🌟 Connections with investors & influencers This year’s focus areas: FinTech, Life Sciences, and Environmental Impact — showcasing Delaware’s dynamic innovation landscape. 💡 Don’t wait—apply now and join the ranks of 52 ventures that have already received $800,000 in funding since 2021! 👉 Visit startup302.org to submit your application and learn more! #Startup302 #InnovationDelaware #Entrepreneurship #TechStartups

🔬 From Scientist to Entrepreneur: Key Insights Are you a scientist thinking about venturing into entrepreneurship? Prof. Thomas Baumert through BaseLaunch, shares valuable advice on making this transition. His tips cover crucial areas such as protecting intellectual property and engaging with investors. 👉 Read the full article for all nine essential tips: https://lnkd.in/eRKD89wv #Biotech #Entrepreneurship #Innovation #Startups #BaseLaunch

📢 CTAN invests over $800k in ICHOR Vascular! Central Texas Angel Network is thrilled to announce its substantial investment of over $800,000 in ICHOR Vascular Inc., a company revolutionizing peripheral clot removal. ICHOR's innovative solution for Peripheral Artery Disease (PAD) and Deep Vein Thrombosis (DVT) eliminates the need for traditional drug therapies and surgeries. Jean Cheever, a key CTAN Deal Team member, said, "ICHOR’s creation of a solution that has the potential to not only enhance patient outcomes but also drive down healthcare costs substantially.” Tim Blair, CEO of ICHOR Vascular, expressed gratitude, "This funding will expedite our efforts to bring our innovative solution to market...we need better tools for patients, and we need to address health economics that plague our health system." Stay tuned for more exciting updates from CTAN as we continue to support groundbreaking ventures! #AngelInvesting #HealthcareInnovation #MedicalTech #StartupFunding #AustinTX #Entrepreneurs #Startups Read the full press release:

#digital #health #funding Qualified Health Launches with $30M Seed Funding to Develop the Infrastructure for Generative AI in Healthcare Aviceda Therapeutics, a biotech startup developing treatments for inflammation, raised a $207.5 million Series C led by Omega Funds and TCGX. Dublin-based FIRE1 , which develops medical devices to monitor heart failure, raised a $120 million round led by Polaris Partners and Elevage Medical Technologies. Francis Medical, a startup creating treatments for prostate, kidney and bladder cancer, raised an $80 million Series C led by Arboretum Ventures and Solas BioVentures. Biotech startup XyloCor Therapeutics, Inc. Therapeutics, which focuses on cardiovascular disease therapies, raised a $67.5 million Series B led by JEITO Capital. Deciphex, a Dublin-based AI-powered digital pathology startup, closed a €31 million Series A led by Molten Ventures. Senseera, an Israeli liquid biopsy startup, raised a $7.1 million seed investment led by Lightspeed Venture Partners. #digitalhealth #startups #venturecapital

Neuranics Lab, a healthcare diagnostics startup, has raised $700K in its seed round led by Inflection Point Ventures (IPV). The proceeds will be used for technology development and clinical validation, enabling the company to progress toward commercial production post-CDSCO licensing. Neuranics is developing a point-of-care blood analyzer capable of delivering complete blood count (CBC) results in less than 10 minutes using just a finger-prick sample. The device, designed for primary and emergency settings, offers low maintenance and high efficiency, making it a game-changer for the healthcare industry. At the same time, life-saving treatments for critical conditions like sepsis, severe anemia, and thrombocytopenia, especially in dengue patients, can be initiated promptly, ensuring timely and effective care. Founders: Praveen Kumar Bhagat and Ashutosh Patra Follow Rise & Shine for daily funding deals. Stay ahead, stay motivated with www.riseshine.in #healthcare #startup #funding